NCT04595864View on ClinicalTrials.gov

Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation

PHASE3RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

November 30, 2024

Study Completion Date

October 30, 2026

Conditions
Hepatocellular CarcinomaLiver Transplantation
Interventions
OTHER

Transarterial chemoinfusion (TAI) with mFOLFOX6 (oxaliplatin, calcium folinate, and 5-FU)

TAI

Trial Locations (1)

210009

RECRUITING

Nanjing Drum tower hospital, Nanjing

All Listed Sponsors
lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

NCT04595864 - Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation | Biotech Hunter | Biotech Hunter